Joe Lewcock
Chief Tech/Sci/R&D Officer bei DENALI THERAPEUTICS INC.
Profil
Gegenwärtig bekleidet Joe Lewcock die Position des Chief Scientific Officer bei Denali Therapeutics, Inc. In der Vergangenheit hatte er die Position des Director-Neuroscience Department bei Genentech, Inc. inne. Er erhielt einen Bachelor-Abschluss von der University of California San Diego und einen Doktortitel von der Johns Hopkins University School of Medicine.
Aktive Positionen von Joe Lewcock
| Unternehmen | Position | Beginn |
|---|---|---|
| DENALI THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Ehemalige bekannte Positionen von Joe Lewcock
| Unternehmen | Position | Ende |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Ausbildung von Joe Lewcock
| University of California San Diego | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DENALI THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
